Asep Medical Holdings Inc. has appointed Dr. Robert E. W. Hancock, the Co-Founder of Asep Inc, as the CEO of the company effective July 5, 2022. Dr. Hancock replaces Rudy Mazzocchi, the former CEO, who has stepped down due to health reasons. Dr. Hancock is the co-founder of Asep Inc. and a expert in infectious diseases.

In recognition of his research work, Dr. Hancock has received numerous awards and honours including the Prix Galien (highest award for Canadian pharmaceutical research and innovation), the Killam Prize (Canada Council's prize for health research), Michael Smith CIHR Researcher of the Year, the ICAAC Aventis Antimicrobial Research Award (leading award worldwide for antimicrobial research) and in 2001 he was inducted as an Officer of the Order of Canada.